Company Filing History:
Years Active: 2017-2024
Title: Innovations of Ryan B Case
Introduction
Ryan B Case is an accomplished inventor based in Alameda, CA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. With a total of 2 patents, his work focuses on advancing medical treatments through cutting-edge research.
Latest Patents
Ryan's latest patents include "Chimeric receptors to DLL3 and methods of use thereof" and "Inhibitory polypeptides specific to WNT inhibitors." The first patent discloses antigen binding molecules, chimeric receptors, and engineered immune cells targeting DLL3. This invention also encompasses vectors, compositions, and methods for treatment and detection using DLL3 antigen binding molecules and engineered immune cells. The second patent is directed towards avimers and peptides, along with various combinations and methods for their production and application.
Career Highlights
Ryan is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Amgen has allowed him to contribute to groundbreaking research and development in the field of immunotherapy.
Collaborations
Ryan collaborates with talented professionals in his field, including Michael John Giffin and Melissa Thomas. These partnerships enhance the quality and impact of his research, fostering an environment of innovation and discovery.
Conclusion
Ryan B Case exemplifies the spirit of innovation in biotechnology through his patents and contributions to medical science. His work continues to pave the way for new therapeutic options that can significantly improve patient outcomes.